Segmentation by type categorises the therapeutic modalities employed across the swollen knee market, highlighting distinct value chains. Pharmacological treatments—including oral NSAIDs, topical analgesics, and intra‑articular corticosteroid injections—represent the largest share, reflecting their ubiquity in both primary‑care and specialist settings. Physical‑therapy modalities such as cryotherapy, compression therapy, and structured exercise programs form a substantial secondary tier, emphasizing non‑drug approaches that reduce reliance on medication. Orthopedic devices—including knee braces, compression sleeves, and pneumatic pumps—capture a niche yet growing segment, driven by patient‑initiated self‑care and preventive strategies. Surgical interventions, primarily arthroscopic debridement and joint replacement, occupy a smaller but high‑value portion, as they are reserved for refractory cases where conservative measures fail. Alternative therapies—including acupuncture, herbal supplements, and low‑level laser therapy—contribute a modest share, catering to patients seeking complementary options. The distribution of these types mirrors clinical guidelines and reimbursement structures, collectively defining the market’s economic landscape.
